VOLPONE JOHN (President) sold 8.5% of their position (24.58K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $109.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/13/2026ACC: 0001501697-26-000070
Officer· President
Since Aug 2025
-24.58K
Net shares
Net seller
$109.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
24.58K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−24.58K
Price / share
$4.44
Trade value
$109.23K
% of position
8.5%
8/12/2026
289.88K→265.31K
Total
Net shares
−24.58K
Net value
-$109.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2026 | S · Sale | −24.58K | $4.44 | $109.23K | 8.5% | 289.88K | 265.31K |
| Total | −24.58K | -$109.23K | ||||||
Derivative Transactions0
No derivative transactions reported